Skip to Content

Join the 'Hepatitis B' group to help and get support from people like you.

Hepatitis B News

Related terms: Chronic Hepatitis B, Hepatitis B, Chronic, HBV

Dynavax Announces FDA Approval of Heplisav-B for Prevention of Hepatitis B in Adults

Posted 10 days ago by Drugs.com

BERKELEY, CA – (Marketwired) – November 9, 2017 – Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved Heplisav-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Heplisav-B is the first new hepatitis B vaccine in the United States in more than 25 years and the only two-dose hepatitis B vaccine for adults. Hepatitis B is an extremely infectious and potentially deadly virus affecting a wide range of adults in the United States. There is no cure for hepatitis B, and infections are on the rise. In 2015, new cases of acute hepatitis B increased by more than 20 percent nationally.(i) Hepatitis B can be prevented through effective vaccination. Current hepatitis B vaccines require three shots over a six-month ... Read more

Related support groups: Hepatitis B, Hepatitis B Vaccine, Hepatitis B Adult Vaccine, Hepatitis B Prevention, Hepatitis B Prophylaxis, Engerix-B, Heplisav-B

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?

Posted 20 Oct 2017 by Drugs.com

FRIDAY, Oct. 20, 2017 – Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily low-dose aspirin therapy may prevent cancer, but there is little clinical evidence on whether regular aspirin use can prevent liver cancer in people with hepatitis B. Researchers from Taiwan analyzed data from close to 205,000 patients with chronic hepatitis B. They found that those on daily aspirin were much less likely to develop liver cancer over five years than those who did not take aspirin. It's important to note, however, that the study only found these associations, but did not establish a cause-and-effect link. The findings are scheduled to be presented Monday at an American Association for the Study of Liver Diseases meeting, in ... Read more

Related support groups: Aspirin, Excedrin, Hepatitis B, Alka-Seltzer, Aggrenox, Excedrin Migraine, Fiorinal, Arthritis Pain, Ecotrin, Fiorinal with Codeine, Bayer Aspirin, Hepatocellular Carcinoma, Soma Compound, Norgesic, Arthritis Pain Formula, Excedrin Extra Strength, Norgesic Forte, Percodan, Anacin, Butalbital Compound

Semen Harbors Wide Range of Viruses

Posted 13 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 13, 2017 – Human semen provides a potential hiding place and breeding ground for a host of dangerous viruses, a new evidence review reports. The analysis of current medical literature revealed genetic evidence of 27 infectious viruses found in semen, including dread-inducing agents like Zika, Ebola, Marburg, Lassa fever and chikungunya, along with mumps, Epstein-Barr and chicken pox. "Clinicians and researchers need to consider the possibility that traditionally non-sexually transmitted viruses can persist in semen, and this therefore raises the possibility of sexual transmission," said lead researcher Alex Salam. He is a clinical researcher with the University of Oxford's epidemic diseases research group in the United Kingdom. However, the presence of viruses in semen does not mean that every virus can be sexually transmitted, the researchers noted. "Detection means ... Read more

Related support groups: Hepatitis C, HIV Infection, Herpes Simplex, Hepatitis B, Viral Infection, Exposure to Hepatitis B Virus, Mumps Polyneuropathy

Hep B Vaccine Should Be Given Sooner: Pediatricians Group

Posted 28 Aug 2017 by Drugs.com

MONDAY, Aug. 28, 2017 – The first dose of the hepatitis B vaccine should be given to babies within 24 hours of birth, new guidelines from the American Academy of Pediatrics say. Until now, the academy had recommended the vaccine be given by the baby's first checkup. Now, the risk of infection has increased with the ongoing opioid crisis, as more moms are getting infected with hepatitis B and passing the virus on to their babies, the authors of the new guidelines explained. "This is the first vaccine a baby receives," said Dr. Flor Munoz, co-author of the recommendation. "It is important that no newborn leaves the birth hospital without it. We encourage pediatricians to advise expectant mothers about the need for their babies to receive the birth dose of the hepatitis B vaccine." Hepatitis B, a viral infection, causes damage to the liver and can become a chronic illness. It can lead to ... Read more

Related support groups: Hepatitis B, Vaccination and Prophlaxis, Labor and Delivery including Augmentation, Exposure to Hepatitis B Virus, Hepatitis B Pediatric Vaccine, Engerix-B Pediatric, Haemophilus B Conjugate (prp-omp) Vaccine/hepatitis B Pediatric Vaccine, Recombivax HB, Comvax, Diphtheria Toxoid/hepatitis B Pediatric Vaccine/pertussis, Acellular/poliovirus Vaccine, Inactivated/tetanus Toxoid, Pediarix

Only About One-Third of Americans Use Condoms: CDC

Posted 10 Aug 2017 by Drugs.com

THURSDAY, Aug. 10, 2017 – Condoms can help prevent pregnancy and the spread of sexually transmitted diseases (STDs), but only about a third of Americans use them, a new federal report shows. "The use of condoms is a public health issue," said report author Casey Copen, a statistician at the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics. "STDs can lead to long-term consequences, such as infertility," she said. "Condoms, when used consistently and correctly, reduce the risk of HIV and STDs." About 20 million new cases of STDs are diagnosed each year in the United States, the CDC said. These infections include human papillomavirus (HPV), gonorrhea, chlamydia, syphilis, hepatitis and HIV. The choice of whether to use a condom or not is influenced by a number of factors. These include: a woman's desire to get pregnant, one's experience using other ... Read more

Related support groups: Birth Control, Contraception, Plan B, Emergency Contraception, Depo-Provera, Nexplanon, Mirena, NuvaRing, Provera, Sprintec, Implanon, Ortho Tri-Cyclen, Hepatitis C, Microgestin Fe 1/20, Tri-Sprintec, Yasmin, Plan B One-Step, Loestrin 24 Fe, Ortho Evra, Lutera

As U.S. Heroin Use Reaches 20-Year High, Cost to Society Soars

Posted 14 Jun 2017 by Drugs.com

WEDNESDAY, June 14, 2017 – Heroin use cost the United States more than $51 billion in 2015, a new study shows. The financial toll includes heroin-related crime and imprisonment. It also includes treatment for addiction as well as chronic infectious diseases contracted through heroin abuse (such as HIV, hepatitis B and C, and tuberculosis), according to researchers from the University of Illinois at Chicago. The total also includes the cost of treating newborns with heroin-related medical conditions; lost productivity on the job and overdose deaths, the researchers said. "The opioid crisis didn't happen overnight," said study co-author Ruixuan Jiang, a pharmacoeconomist at UIC. In a university news release, she said the number of U.S. heroin users doubled from 2000 to 2013. Study co-author Simon Pickard, a professor of pharmacy systems, has been tracking the rise in heroin use for ... Read more

Related support groups: Opiate Dependence, Opiate Withdrawal, Heroin, Drug Dependence, HIV Infection, Hepatitis B, Substance Abuse, Tuberculosis, Toxic Reactions Incl Drug and Substance Abuse, Substance Abuse - Cocaine

Hepatitis Infection May Raise Risk for Parkinson's Disease

Posted 30 Mar 2017 by Drugs.com

THURSDAY, March 30, 2017 – People with the liver infection hepatitis may be at heightened risk of developing Parkinson's disease, a large new study suggests. The study, published online March 29 in Neurology, is the second in the past year to link hepatitis to Parkinson's. Specifically, the new study found that people who'd been infected with hepatitis B or C were 51 percent to 76 percent more likely to develop Parkinson's, compared to people who'd never had hepatitis. The researchers don't know why the connection exists. And the study cannot prove a cause-and-effect link. But the association between Parkinson's disease and hepatitis appears to be "strong," according to Dr. Michael Okun, national medical director of the Parkinson's Foundation. Last year, a study in Taiwan found that people with hepatitis C faced an increased risk of Parkinson's. Now the new findings, based on millions ... Read more

Related support groups: Hepatitis C, Parkinson's Disease, Hepatitis B, Parkinsonism, Parkinsonian Tremor, Exposure to Hepatitis B Virus

Better Efforts Could Help Rid the U.S. of Hepatitis B, C: Report

Posted 28 Mar 2017 by Drugs.com

TUESDAY, March 28, 2017 – Improved prevention, screening and treatment could help eliminate hepatitis B and C as serious public health problems in the United States and save nearly 90,000 lives by 2030, according to a new report. About 1.3 million people in the United States have chronic hepatitis B and about 2.7 million have chronic hepatitis C. These infections cause about 80 percent of liver cancer cases worldwide. Liver cancer incidence in the United States rose 38 percent between 2003 and 2012. Liver cancer deaths increased 56 percent during that time, primarily due to viral hepatitis, according to the report from the National Academies of Sciences, Engineering, and Medicine. "Viral hepatitis is simply not a sufficient priority in the United States," said report committee chair Dr. Brian Strom, chancellor and professor at Rutgers University Biomedical and Health Sciences in ... Read more

Related support groups: Hepatitis C, Hepatitis B, Hepatitis B Adult Vaccine, Hepatitis B Prevention, Twinrix, Exposure to Hepatitis B Virus, Hepatitis B Prophylaxis, Engerix-B, Vaccination and Prophlaxis, Hepatitis A Adult Vaccine/hepatitis B Adult Vaccine

Use of Needle Exchange Programs Up Dramatically in 10 Years: CDC

Posted 30 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 30, 2016 – Although there was a significant increase in the use of syringe services programs (SSPs) – more commonly known as needle exchange programs – across the United States over the past decade, many injection drug users don't always use sterile needles, a federal government report says. Previously used needles put drug users at risk for infectious diseases such as HIV and hepatitis B and C, the report noted. Needle exchange programs provide sterile needles and syringes to injection drug users. These programs also refer drug users to prevention, care and treatment services. Researchers from the U.S. Centers for Disease Control and Prevention looked at data from injection drug users in 22 cities with high rates of HIV. In 2015, 54 percent of injection drug users said they used a needle exchange program in the past year. That was up significantly compared to the 36 ... Read more

Related support groups: Opiate Dependence, Hepatitis C, Drug Dependence, HIV Infection, Pre-Exposure Prophylaxis, Hepatitis B, Substance Abuse, Hepatitis B Prevention, Toxic Reactions Incl Drug and Substance Abuse, Exposure to Hepatitis B Virus, Hepatitis B Prophylaxis

FDA Approves Gilead’s Vemlidy (tenofovir alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection

Posted 15 Nov 2016 by Drugs.com

FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 10, 2016-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vemlidy (tenofovir alafenamide, TAF) 25mg, a once-daily treatment for adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. Vemlidy has a boxed warning in its product label regarding the risks of lactic acidosis/severe hepatomegaly with steatosis and post-treatment severe acute exacerbation of hepatitis B. See below for important safety information. Vemlidy is a novel, targeted prodrug of tenofovir that has demonstrated antiviral efficacy similar to and at a dose less than one-tenth that of Gilead’s Viread® (tenofovir disoproxil fumarate, TDF) 300mg. Data show that because Vemlidy has greater plasma stability and more efficiently delivers tenofovir to hepatocytes compared to Viread, it ca ... Read more

Related support groups: Hepatitis B, Viread, Tenofovir, Vemlidy, Tenofovir Alafenamide

Robotic Surgical Tools Tough to Keep Clean

Posted 1 Nov 2016 by Drugs.com

TUESDAY, Nov. 1, 2016 – Even with repeated cleanings, it's virtually impossible to remove all contamination from robotic surgical instruments, a new study suggests. "One of the top priorities for hospitals is to treat patients safely and with minimal risk of infection," said study author Yuhei Saito, an assistant professor at the University of Tokyo Hospital in Japan. "Our results show that surgical instruments could be placing patients at risk due to current cleaning procedures. One way to address this issue is to establish new standards for cleaning surgical instruments, including multi-part robotic tools," Saito said in a news release from the Society for Healthcare Epidemiology of America. Over the course of 21 months, the researchers assessed protein residue on 132 robotic and standard surgical instruments that were cleaned according to manufacturers' instructions. The cleanings ... Read more

Related support groups: Infections, Surgery, Bacterial Infection, Hepatitis C, Hepatitis B, Hepatitis A, Surgical Prophylaxis, Cardiothoracic Surgery, Gastrointestinal Surgery

FDA Medwatch Alert: Direct-Acting Antivirals for Hepatitis C: Drug Safety Communication - Risk of Hepatitis B Reactivating

Posted 10 Oct 2016 by Drugs.com

ISSUE: The FDA is warning about the risk of hepatitis B virus (HBV) becoming an active infection again in any patient who has a current or previous infection with HBV and is treated with certain direct-acting antiviral (DAA) medicines for hepatitis C virus. In a few cases, HBV reactivation in patients treated with DAA medicines resulted in serious liver problems or death. HBV reactivation usually occurred within 4-8 weeks. As a result, FDA is requiring a Boxed Warning, our most prominent warning, about the risk of HBV reactivation to be added to the drug labels of these DAAs directing health care professionals to screen and monitor for HBV in all patients receiving DAA treatment. This warning will also be included in the patient information leaflet or Medication Guides for these medicines. BACKGROUND: Direct-acting antiviral medicines are used to treat chronic hepatitis C virus (HCV) ... Read more

Related support groups: Hepatitis C, Harvoni, Hepatitis B, Sovaldi, Epclusa, Zepatier, Sofosbuvir, Daklinza, Viekira Pak, Ledipasvir/sofosbuvir, Daclatasvir, Sofosbuvir/velpatasvir, Technivie, Ombitasvir/paritaprevir/ritonavir, Olysio, Simeprevir, Viekira XR, Elbasvir/grazoprevir, Dasabuvir/ombitasvir/paritaprevir/ritonavir

Tips for Avoiding Back-to-School Germs, Illnesses

Posted 23 Sep 2016 by Drugs.com

FRIDAY, Sept. 23, 2016 – Kids and germs seem to go together like peanut butter and jelly. But, there are ways that parents can help protect their kids from the usual barrage of back-to-school illnesses, a health expert says. Make sure children get plenty of sleep and eat a well balanced diet, advises Jacqueline Stout-Aguilar. She's a registered nurse and an assistant professor at the Texas A&M College of Nursing. Most kids need at least nine hours of sleep each night, Stout-Aguilar said. It's also a good idea to make sure children get enough vitamin C to boost their immune system, she added. Parents should also teach their children how to contain germs and keep their hands clean. Show kids how to cover their coughs and sneezes with the inside of their elbow or a tissue, Stout-Aguilar said. She said kids must also be taught how to wash their hands properly. "It is important to wash your ... Read more

Related support groups: Influenza, Pre-Exposure Prophylaxis, Hepatitis B, Hepatitis A, Measles, Tetanus Toxoid, Rubella, Pneumococcal 23-polyvalent Vaccine, Varicella Virus Vaccine, Pneumovax 23, Rubella Virus Vaccine, FluLaval, Measles Virus Vaccine, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, FluMist, Kinrix, Fluzone, Afluria, ProQuad, Influenza Virus Vaccine, Inactivated

Serious Infections Tied to Suicide Risk

Posted 10 Aug 2016 by Drugs.com

WEDNESDAY, Aug. 10, 2016 – People hospitalized for serious infections may face an increased risk of dying by suicide, and researchers suspect there's a biological reason for it. In a study of over 7 million people, Danish researchers found that those who'd been hospitalized for infections were 42 percent more likely to die of suicide compared to people with no history of serious infection. People hospitalized for HIV/AIDS or the liver infection hepatitis showed the highest risk – more than twice that of people without those diseases, the study found. Although the study couldn't prove a cause-and-effect link, the study authors and at least one other brain health expert think the increased risk of suicide after infection might not simply reflect the psychological impact of serious illness. Instead, infections might directly contribute to suicide risk by causing inflammation in the ... Read more

Related support groups: Depression, Major Depressive Disorder, Hepatitis C, HIV Infection, Postpartum Depression, Dysthymia, Hepatitis B, Seasonal Affective Disorder, Hepatitis A, Neurotic Depression, Depressive Psychosis, Chronic Active Hepatitis, Infectious Hepatitis

Ridding U.S. of Hepatitis B, C as 'Public Health Problem' Possible: Experts

Posted 11 Apr 2016 by Drugs.com

MONDAY, April 11, 2016 – Experts say there's real hope in someday ridding the United States of the "public health problem" of hepatitis B and C infection. The two viral strains cause serious, often fatal, liver disease for tens of thousands of Americans each year. The comprehensive new report is from a panel of experts at the U.S. National Academies of Sciences, Engineering, and Medicine. They believe that the advent of a powerful new vaccine and medicines could help drastically lower hepatitis B and C rates across the country. Still, to reach that goal will take time and considerable resources, the report said. "Ending illness and deaths from hepatitis C depends on both stopping the disease's progression in its early stages and reversing the course of advanced disease," the committee said in a news release. According to the report, between 700,000 and 1.4 million Americans have ... Read more

Related support groups: Hepatitis C, Cirrhosis, Hepatitis B, Liver Cirrhosis, Exposure to Hepatitis B Virus, Hepatic Tumor

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Exposure to Hepatitis B Virus, Infectious Hepatitis

Related Drug Support Groups

Pegasys, Baraclude, Viread, PegIntron, tenofovir, interferon alfa-2b, Hepsera, entecavir, lamivudine, view more... Intron A, Vemlidy, Epivir, peginterferon alfa-2b, peginterferon alfa-2a, Epivir-HBV, tenofovir alafenamide, telbivudine, Tyzeka, adefovir